Literature DB >> 10961196

Report of sexually transmitted diseases by HIV infected men during follow up: time to target the HIV infected?

R N Machekano1, M T Bassett, P S Zhou, M T Mbizvo, A S Latif, D A Katzenstein.   

Abstract

OBJECTIVES: To compare the rate of self reported sexually transmitted diseases (STDs) among HIV infected men with men who remained HIV negative during follow up of a Harare male factory cohort.
METHODS: Male factory workers were offered enrolment and behavioural data were collected at entry then every 6 months, along with HIV testing. Self report of STDs was used to calculate incidence per 100 person years. Cox proportional hazards models examined independent risk factors for STDs, with hazard ratios (HRs).
RESULTS: At entry 20% of men were HIV infected and 11% reported STDs in the previous year. A total of 2777 (82%) of 3383 men enrolled were followed at least once. Compared with men who remained HIV negative, seroconverters had the highest incidence of STDs (16.8 per 100 person years; IRR = 3.3, 95% CI = 2.5-4.3); men enrolled HIV positive also reported higher STD incidence (14.5 per 100 person years, IRR = 2.8; 95% CI 2.3-5.5). Among HIV positive men, the only independent risk factor for report of urethral discharge was history of multiple partners (HR = 10, 95% CI 1.4-73.2).
CONCLUSION: HIV positive men reported threefold higher incidence of STDs than HIV negative men, many related to high risk sexual behaviour.

Entities:  

Mesh:

Year:  2000        PMID: 10961196      PMCID: PMC1744145          DOI: 10.1136/sti.76.3.188

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  16 in total

Review 1.  Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility.

Authors:  G Marks; S Burris; T A Peterman
Journal:  AIDS       Date:  1999-02-25       Impact factor: 4.177

Review 2.  Sexual transmission of HIV: infectiousness and prevention.

Authors:  P L Vernazza; J J Eron; S A Fiscus; M S Cohen
Journal:  AIDS       Date:  1999-02-04       Impact factor: 4.177

3.  Sexually transmitted diseases: a survey of case management in Malawi.

Authors:  D A Chilongozi; C C Daly; L Franco; N G Liomba; G Dallabetta
Journal:  Int J STD AIDS       Date:  1996-07       Impact factor: 1.359

4.  Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group.

Authors:  M S Cohen; I F Hoffman; R A Royce; P Kazembe; J R Dyer; C C Daly; D Zimba; P L Vernazza; M Maida; S A Fiscus; J J Eron
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

5.  Risk factors for HIV infection at enrollment in an urban male factory cohort in Harare, Zimbabwe.

Authors:  M T Bassett; W C McFarland; S Ray; M T Mbizvo; R Machekano; J H van de Wijgert; D A Katzenstein
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-11-01

6.  Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection.

Authors:  O A Anzala; N J Nagelkerke; J J Bwayo; D Holton; S Moses; E N Ngugi; J O Ndinya-Achola; F A Plummer
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

7.  HIV seroincidence and correlates of seroconversion in a cohort of male factory workers in Harare, Zimbabwe.

Authors:  M T Mbizvo; R Machekano; W McFarland; S Ray; M Bassett; A Latif; D Katzenstein
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

8.  Individual counseling of patients with sexually transmitted diseases. A way to improve partner notification in a Zambian setting?

Authors:  E Faxelid; G Tembo; J Ndulo; I Krantz
Journal:  Sex Transm Dis       Date:  1996 Jul-Aug       Impact factor: 2.830

9.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial.

Authors:  H Grosskurth; F Mosha; J Todd; E Mwijarubi; A Klokke; K Senkoro; P Mayaud; J Changalucha; A Nicoll; G ka-Gina
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

10.  Condoms for men, not women. Results of brief promotion programs.

Authors:  D A Cohen; C Dent; D MacKinnon; G Hahn
Journal:  Sex Transm Dis       Date:  1992 Sep-Oct       Impact factor: 2.830

View more
  6 in total

1.  Efforts to Control Sexually Transmitted Diseases As a Means to Limit HIV Transmission: Pros and Cons.

Authors:  Gina Dallabetta; Madaline Feinberg
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

Review 2.  Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention.

Authors:  Seth C Kalichman; Jennifer Pellowski; Christina Turner
Journal:  Sex Transm Infect       Date:  2011-02-17       Impact factor: 3.519

3.  Sexually transmitted infections among HIV-infected adults in HIV care programs in Kenya: a national sample of HIV clinics.

Authors:  Benson Singa; Sara Nelson Glick; Naomi Bock; Judd Walson; Linda Chaba; James Odek; R Scott McClelland; Gaston Djomand; Hongjiang Gao; Grace John-Stewart
Journal:  Sex Transm Dis       Date:  2013-02       Impact factor: 2.830

4.  High burden of STIs among HIV-infected adults prior to initiation of ART in South Africa: a retrospective cohort study.

Authors:  Mark N Lurie; Kipruto Kirwa; Johann Daniels; Marcel Berteler; Seth C Kalichman; Catherine Mathews
Journal:  Sex Transm Infect       Date:  2014-05-16       Impact factor: 3.519

5.  Co-infection of human immunodeficiency virus and sexually transmitted infections in circumcised and uncircumcised cases in India.

Authors:  Charu Nayyar; Ram Chander; Poonam Gupta; B L Sherwal
Journal:  Indian J Sex Transm Dis AIDS       Date:  2014 Jul-Dec

6.  Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis.

Authors:  Cecily Banura; Florence M Mirembe; Jackson Orem; Anthony K Mbonye; Simon Kasasa; Edward K Mbidde
Journal:  Infect Agent Cancer       Date:  2013-07-10       Impact factor: 2.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.